Cardiac resistance to Adriamycin in transgenic mice expressing a rat α-cardiac myosin heavy chain/human multiple drug resistance 1 fusion gene

Human Gene Therapy

Volumn 10, Issue 8, 1999, Pages 1269-1279

  Dell'Acqua, Giorgio ^a,b   Polishchuck, Roman ^c   Fallon, John T ^a   Gordon, Jon W ^a,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DRUG RESISTANCE; ELECTRON MICROSCOPY; FEMALE; FUSION GENE; GENE OVEREXPRESSION; GENE TRANSFER; HEART MUSCLE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROSCOPY; MOUSE; NONHUMAN; TRANSGENIC MOUSE;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; ARTIFICIAL GENE FUSION; DOXORUBICIN; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GENE THERAPY; HEART; HUMANS; MALE; MICE; MICE, TRANSGENIC; MYOSIN HEAVY CHAINS; P-GLYCOPROTEIN; RATS; TUMOR CELLS, CULTURED;

ANIMALIA; MUS MUSCULUS;

EID: 0033587057     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017950     Document Type: Article

References (66)

1. AGAH, R., FRENKEL, P.A., FRENCH, B.A., MICHAEL, L.H., OVERBEEK, P.A., and SCHNEIDER, M.D. (1997). Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangements in adult ventricular muscle in vivo. J. Clin. Invest. 100, 169-179.
2. ALDERTON, P.M., GROSS, J., and GREEN, M.D. (1992). Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res. 52, 194-201.
3. BOTTONE, A.E., DE BEER, E.L., and VOEST, E.E. (1997). Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system. J. Mol. Cell. Cardiol. 29, 1001-1008.
4. BUTTRICK, P.M., KAPLAN, M.L., KITSIS, R.N., and LEINWAND, L.A. (1993). Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Discordance with in vitro results. Circ. Res. 6, 1211-1217.
5. CHOI, K.H., CHEN, C.J., KRIEGLER, M., and RONINSON, I.B. (1988). An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene. Cell 53, 519-529.
6. DALESANDRO, J., AKIMOTO, H., GORMAN, C.M., MCDONALD, T.O., THOMAS, R., LIGGITT, H.D., and ALLEN, M.D. (1996). Gene therapy for donor hearts: Ex vivo liposome-mediated transfection. J. Thorac. Cardiovasc. Surg. 111, 416-421.
7. DANO, K. (1973). Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta 323, 466-483.
8. DAVIES, K.J., and DOROSHOW, J.H. (1986). Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 61, 3060-3067.
9. DOROSHOW, J.H., and DAVIES, K.J. (1986). Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261, 3068-3074.
10. DUSONCHET, L., CROSTA, L., BELLINI, O., FLANDINA, C., PALMERI, S., VALVO, F., and RAUSA, L. (1984). The influence of multiple treatment with doxorubicin or 4′-deoxy-doxorubicin on the DNA synthesis and morphology of mouse heart. Int. J. Tissue React. 6, 81-89.
11. FISHER, K.J., JOOS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 3, 306-312.
12. FLENS, M.J., ZAMAN, G.J., VAN DER VALK, P., IZQUIERDO, M.A., SCHROEIJERS, A.B., SCHEFFER, G.L., VAN DER GROEP, P., DE HAAS, M., MEIJER, C.J., and SCHEPER, R.J. (1996). Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148, 1237-1247.
13. FRANZ, W.M., BREVES, D., KLINGEL, K., BREM, G., HOFSCHNEIDER, P.H., and KANDOLF, R. (1993). Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice. Circ. Res. 73, 629-638.
14. FRANZ, W.M., ROTHMANN, T., FREY, N., and KATUS, H.A. (1997). Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters. Cardiovasc. Res. 35, 560-566.
15. GALSKI, H., SULLIVAN, M., WILLINGHAM, M.C., CHIN, K.V., GOTTESMAN, M.M., PASTAN, I., and MERLINO, G.T. (1989). Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: Resistance to daunomycin-induced leukopenia. Mol. Cell. Biol. 10, 4357-4363.
16. GALSKI, H., MERLINO, G.T., GOTTESMAN, M.M., and PASTAN, I. (1991). Expression of a human multidrug-resistance cDNA (MDR1) under the control of a beta-actin promoter in transgenic mice. BiolTechnology 16, 103-124.
17. GILGENKRANTZ, H., DUBOC, D., JUILLARD, V., COUTON, D., PAVIRANI, A., GUILLET, J.G., BRIAND, P., and KAHN, A. (1995). Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Hum. Gene Ther. 6, 1265-1274.
18. GIORDANO, F.J., PING, P., MCKIRNAN, M.D., NOZAKI, S., DEMARIA, A.N., DILLMANN, W.H., MATHIEU-COSTELLO, O., and HAMMOND, H.K. (1996). Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2, 534-539.
19. GLISIN, V., CRKVENJAKOV, R., and BYUS, C. (1974). Ribonucleic acid isolation by cesium chloride centrifugation. Biochemistry 13, 2633-2637.
20. GOLDSTEIN, L.J. (1996). MDR1 gene expression in solid tumours. Eur. J. Cancer 32A, 1039-1050.
21. GOLDSTEIN, L.J., GALSKI, H., FOJO, A., WILLINGHAM, M., LAI, S., GAZDAR, A., PIRKER, R., GREEN, A., CRIST, W., BRODEUR, G.M., LIEBER, M., COSSMAN, J., GOTTESMAN, M.M., and PASTAN, I. (1989). Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81, 116-124.
22. GORDON, J.W., and RUDDLE, F.H. (1981). Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 214, 1244-1246.
23. GORDON, J.W., and RUDDLE, F.H. (1983). Gene transfer into mouse embryos: Production of transgenic mice by pronuclear injection. Methods Enzymol. 101, 411-433.
24. GORDON, J.W., SCANGOS, G.A., PLOTKIN, D.J., BARBOSA, J.A., and RUDDLE, F.H. (1980). Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. U.S.A. 77, 7380-7384.
25. GRISCELLI, F., GILARDI-HEBENSTREIT, P., HANANIA, N., FRANZ, W.M., OPOLON, P., PERRICAUDET, M., and RAGOT, T. (1998). Heart-specific targeting of β-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors. Hum. Gene Ther. 9, 1919-1928.
26. GUSTAFSON, T.A., MARKHAM, B.E., BAHL, J.J., and MORKIN, E. (1987). Thyroid hormone regulates expression of a transfected alpha-myosin heavy-chain fusion gene in fetal heart cells. Proc. Natl. Acad. Sci. U.S.A. 84, 3122-3126.
27. HENDERSON, I.C., and FREI, T.E. (1979). Adriamycin and the heart. N. Engl. J. Med. 300, 310-312. [Editorial]
28. HENDERSON, I.C., and FREI, E. (1980). Adriamycin cardiotoxicity. Am. Heart J. 99, 671-674.
29. JULIANO, R.L., and LING, V. (1976). A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 152-162.
30. KANG, Y.J., CHEN, Y., and EPSTEIN, P.N. (1996). Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 271, 12610-12616.
31. KANG, Y.J., CHEN, Y., YU, A., VOSS-MCCOWAN, M., and EPSTEIN, P.N. (1997). Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J. Clin. Invest. 100, 1501-1506.
32. KARTNER, N., RIORDAN, J.R., and LING, V. (1983). Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, 1285-1288.
33. KARTNER, N., EVERNDEN-PORELLE, D., BRADLEY, G., and LING, V. (1985). Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature (London) 316, 820-823.
34. KATZ, E.B., STEINHELPER, M.E., DELCARPIO, J.B., DAUD, A.I., CLAYCOMB, W.C., and FIELD, L.J. (1992). Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV 40 T-antigen transgene. Am. J. Physiol. 262, H1867-H1876.
35. KAVALLARIS, M. (1997). The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance. Anticancer Drugs 8, 17-25.
36. KITSIS, R.N., BUTTRICK, P.M., MCNALLY, E.M., KAPLAN, M.L., and LEINWAND, L.A. (1991). Hormonal modulation of a gene injected into rat heart in vivo. Proc. Natl. Acad. Sci. U.S.A. 88, 4138-4142.
37. LAIRD, P.W., ZIJDERVELD, A., LINDERS, K., RUDNICKI, M.A., JAENISCH, R., and BERNS, A. (1991). Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19, 4293.
38. LAMBERTENGHI-DELILIERS, G., ZANON, P.L., POZZOLI, E.F., and BELLINI, O. (1976). Myocardial injury induced by a single dose of Adriamycin: An electron microscopic study. Tumori 62, 517-528.
39. LI, X., KOBAYASHI, H., HOLLAND, J.F., and OHNUMA, T. (1993). Expression of dihydrofolate reductase and multidrug resistance genes in trimetrexate-resistant human leukemia cell lines. Leukemia Res. 17, 483-490.
40. LINK, G., TIROSH, R., PINSON, A., and HERSHKO, C. (1996). Role of iron in the potentiation of anthracycline cardiotoxicity: Identification of heart cell mitochondria as a major site of iron-anthracycline interaction. J. Lab. Clin. Med. 127, 272-278.
41. LORICO, A., RAPPA, G., FLAVELL, R.A., and SARTORELLI, A.C. (1996). Double knockout of the MRP gene leads to increased drug sensitivity in vitro. Cancer Res. 56, 5351-5355.
42. MAHDAVI, V., PERIASAMY, M., and NADAL-GINARD, B. (1982). Molecular characterization of two myosin heavy chain genes expressed in the adult heart. Nature (London) 297, 659-664.
43. MYERS, C.E., MCGUIRE, W.P., LISS, A.H., IFRIM, I., GROTZINGER, K., and YOUNG, R.D. (1977). Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science 197, 165-167.
44. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
45. OLSON, R.D., and MUSHLIN, P.S. (1990). Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses. FASEB J. 4, 3076-3086.
46. QIN, L., CHAVIN, K.D., DING, Y., TAHARA, H., FAVARO, J.P., WOODWARD, J.E., SUZUKI, T., ROBBINS, P.D., LOTZE, M.T., and BROMBERG, J.S. (1996). Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156, 2316-2323.
47. RIORDAN, J.R., and LING, V. (1979). Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J. Biol. Chem. 254, 12701-12705.
48. RIORDAN, J.R., DEUCHARS, K., KARTNER, N., ALON, N., TRENT, J., and LING, V. (1985). Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (London) 316, 817-819.
49. ROSENOFF, S.H., OLSON, H.M., YOUNG, D.M., BOSTICK, F., and YOUNG, R.C. (1975). Adriamycin-induced cardiac damage in the mouse: A small-animal model of cardiotoxicity. J. Natl. Cancer Inst. 55, 191-194.
50. ROTHMANN, T., KATUS, H.A., HARTONG, R., PERRICAUDET, M., and FRANZ, W.M. (1996). Heart muscle-specific gene expression using replication defective recombinant adenovirus. Gene. Ther. 3, 919-926.
51. SAWA, Y., SUZUK, K., BAI, H.Z., SHIRAKURA, R., MORISHITA, R., KANEDA, Y., and MATSUDA, H. (1995). Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. Circulation 92, 11479-11482.
52. SHINKEL, A.H., SMIT, J.J., VAN TELLINGEN, O., BEUENEN, J.H., WAGENAAR, E., VAN DEEMTER, L., MOL, C.A., VAN DER VALK, M.A., ROBANUS-MAANDAG, E.C., TE RIELE, H.P., BERNS, A.J., and BORST, P. (1994). Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
53. SHINKEL, A.H., MAYER, U., WAGENAAR, E., MOL, C.A., VAN DEEMTER, L., SMIT, J.J., VAN DER VALK, M.A., VOORDOUW, A.C., SPITS, H., VAN TELLINGEN, O., ZIJLMANS, J.M., FIBBE, W.E., and BORST, P. (1997). Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. U.S.A. 94, 4028-4033.
54. SKOVSGAARD, T. (1978). Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res. 38, 4722-4727.
55. SOLCIA, E., BALLERINI, L., BELLINI, O., MAGRINI, U., BERTAZZOLI, C., TOSANA, G., SALA, L., BALCONI, F., and RALLO, F. (1981). Cardiomyopathy of doxorubicin in experimental animals. Factors affecting the severity, distribution and evolution of myocardial lesions. Tumori 67, 461-472.
56. SOLEM, L.E., HELLER, L.J., and WALLACE, K.B. (1996). Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by doxorubicin. J. Mol. Cell. Cardiol. 28, 1023-1032.
57. SPADARI, S., PEDRALI-NOY, G., FOCHER, F., MONTECUCCO, A., BORDONI, T., GERONI, C., GIULIANI, F.C., VENTRELLA, G., ARCAMONE, F., and CIARROCCHI, G. (1986). DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs. Anticancer Res. 6, 935-940.
58. SUBRAMANIAM, A., JONES, W.K., GULICK, J., WERT, S., NEUMANN, J., and ROBBINS, J. (1991). Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266, 24613-24620.
59. TEWEY, K.M., ROWE, T.C., YANG, L., HALLIGAN, B.D., and LIU, L.F. (1984). Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226, 466-168.
60. THIEBAUT, F., TSURUO, T., HAMADA, H., GOTTESMAN, M.M., PASTAN, I., and WILLINGHAM, M.C. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 84, 7735-7738.
61. TSIKA, R.W., BAHL, J.J., LEINWAND, L.A., and MORKIN, E. (1990). Thyroid hormone regulates expression of a transfected human alpha-myosin heavy-chain fusion gene in fetal rat heart cells. Proc. Natl. Acad. Sci. U.S.A. 87, 379-383.
62. UEDA, K., CARDARELLI, C., GOTTESMAN, M.M., and PASTAN, I. (1987). Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. U.S.A. 84, 3004-3008.
63. VALVERDE, M.A., BOND, T.D., HARDY, S.P., TAYLOR, J.C., HIGGINS, C.F., ALTAMIRANO, J., and ALVAREZ-LEEFMANS, F.J. (1996). The multidrug-resistance P-glycoprotein modulates cell regulatory volume decrease. EMBO J. 15, 4460-4468.
64. VAN HELVOORT, A., SMITH, A.J., SPRONG, H., FRITZSCHE, I., SCHINKEL, A.H., BORST, P., and VAN MEER, G. (1996). MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87, 507-517.
65. WANG, J., MA, Y., and KNECHTLE, S.J. (1996). Adenovirus-mediated gene transfer into rat cardiac allografts. Comparison of direct injection and perfusion. Transplantation 61, 1726-1729.
66. YEN, H., OBERLEY, T.D., VICHITBANDHA, S., HO, Y., and ST. CLAIR, D.T. (1996). The protective role of manganese superoxide dismutase against Adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 98, 1253-1260.